Skip to content

KLRS KLRS Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$19.78M-8.1%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$6.5M+11.4%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$34.38M-19.1%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$17.36M-14.8%
Regenxbio logo
RegenxbioRGNX
$45.54M-12.6%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$785K-39.8%

Other financials

Income statement

See full
Operating income-$11.8M-14.3%
Net income-$10.9M-6.5%
EPS (diluted)-$0.46+81.7%

Balance sheet

See full
Cash & equivalents$34.4M-65.9%
Total debt$1.4M
Total equity$68.6M+7.3%
Total assets$109.8M+6.5%

Cash flow

See full
Operating cash flow-$11.6M-55.6%
CapEx$17.0K
Free cash flow-$7.1M

Valuation

See full
Market cap$96.83M+136%
Enterprise value$63.82M

Returns & leverage

See full
Return on equity-66.6%
Debt / equity
Current ratio12.2×-2.1×

Where this comes from

Reported directly by KLRS in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: KLRS’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about KLRS's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KLRS's operating lease ROU assets?
KLRS (KLRS) reported operating lease ROU assets of $1.43M in Q1 2026.
What is the long-term trend for KLRS's operating lease ROU assets?
Over 4 years (2021 to 2025), KLRS's operating lease ROU assets has grown at a -52.8% compound annual growth rate (CAGR), from $29.74M to $1.48M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.